FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311585569> ?p ?o ?g. }

• W4311585569 endingPage "384" @default.
• W4311585569 startingPage "370" @default.
• W4311585569 abstract "Background: Preeclampsia is a complicated syndrome with marked heterogeneity. The biomarker-based classification for this syndrome is more constructive to the targeted prevention and treatment of preeclampsia. It has been reported that preeclamptic patients had elevated microRNA-155 (miR-155) in placentas or circulation. Here, we investigated the characteristics of patients with high placental miR-155 (pl-miR-155). Methods: Based on the 95th percentile (P95) of pl-miR-155 in controls, preeclamptic patients were divided into high miR-155 group (≥P95) and normal miR-155 group (<P95). The changes of placental pathology, clinical manifestations, and placental transcriptome of preeclamptic patients were clustered by t-distributed stochastic neighbor embedding and hierarchical clustering analysis. The placental restricted miR-155 overexpression mouse model was constructed, and the phenotype, placental pathology, and transcriptome were evaluated. Furthermore, the therapeutic potential of antagonist of miR-155 was explored by administrating with antagomir-155. Results: About one-third of preeclamptic patients had high pl-miR-155 expression, which was positively correlated with circulating miR-155 levels. These patients could be clustered as 1 group, according to clinical manifestation, placental pathology, or transcriptomes by t-distributed stochastic neighbor embedding and hierarchical clustering analysis. Further, the pregnant mice with placental restricted miR-155 overexpression could simulate the changes of clinical signs, pathology, and transcriptome of placentas in patients with high pl-miR-155. AntagomiR-155 treatment relieved the preeclampsia-like phenotype and improved the placental vascular development in mice. Conclusions: There is at least 1 type of preeclampsia with upregulated miR-155 presenting more severe clinical manifestations. MiR-155 may be a potential therapeutic target in patients with high pl-miR-155." @default.
• W4311585569 created "2022-12-27" @default.
• W4311585569 creator A5001111016 @default.
• W4311585569 creator A5005859926 @default.
• W4311585569 creator A5006012404 @default.
• W4311585569 creator A5024409537 @default.
• W4311585569 creator A5027592431 @default.
• W4311585569 creator A5028490219 @default.
• W4311585569 creator A5030723398 @default.
• W4311585569 creator A5032544653 @default.
• W4311585569 creator A5037062221 @default.
• W4311585569 creator A5037407918 @default.
• W4311585569 creator A5038221232 @default.
• W4311585569 creator A5040474777 @default.
• W4311585569 creator A5040644812 @default.
• W4311585569 creator A5048379858 @default.
• W4311585569 creator A5051078713 @default.
• W4311585569 creator A5051092144 @default.
• W4311585569 creator A5056986214 @default.
• W4311585569 creator A5057612778 @default.
• W4311585569 creator A5062053302 @default.
• W4311585569 creator A5066771874 @default.
• W4311585569 creator A5068087689 @default.
• W4311585569 creator A5068252474 @default.
• W4311585569 creator A5083093957 @default.
• W4311585569 creator A5083465771 @default.
• W4311585569 date "2023-02-01" @default.
• W4311585569 modified "2023-10-18" @default.
• W4311585569 title "Elevated Placental microRNA-155 Is a Biomarker of a Preeclamptic Subtype" @default.
• W4311585569 cites W1981662437 @default.
• W4311585569 cites W1981697660 @default.
• W4311585569 cites W1993474041 @default.
• W4311585569 cites W2001926195 @default.
• W4311585569 cites W2017330096 @default.
• W4311585569 cites W2019842783 @default.
• W4311585569 cites W2036611042 @default.
• W4311585569 cites W2058972167 @default.
• W4311585569 cites W2059176552 @default.
• W4311585569 cites W2059901199 @default.
• W4311585569 cites W2075067207 @default.
• W4311585569 cites W2095759878 @default.
• W4311585569 cites W2111778724 @default.
• W4311585569 cites W2140819420 @default.
• W4311585569 cites W2146864915 @default.
• W4311585569 cites W2154652221 @default.
• W4311585569 cites W2171945997 @default.
• W4311585569 cites W2261068749 @default.
• W4311585569 cites W2295247670 @default.
• W4311585569 cites W2414982922 @default.
• W4311585569 cites W2586389077 @default.
• W4311585569 cites W2611788581 @default.
• W4311585569 cites W2740330569 @default.
• W4311585569 cites W2756050015 @default.
• W4311585569 cites W2775362208 @default.
• W4311585569 cites W2783248663 @default.
• W4311585569 cites W2884268977 @default.
• W4311585569 cites W2893253642 @default.
• W4311585569 cites W2902133065 @default.
• W4311585569 cites W2953684040 @default.
• W4311585569 cites W2960659672 @default.
• W4311585569 cites W2979942282 @default.
• W4311585569 cites W3003339157 @default.
• W4311585569 cites W3004084798 @default.
• W4311585569 cites W3008048245 @default.
• W4311585569 cites W3086947331 @default.
• W4311585569 cites W3090502644 @default.
• W4311585569 cites W3118637236 @default.
• W4311585569 cites W3118686410 @default.
• W4311585569 cites W3126180845 @default.
• W4311585569 cites W3135786171 @default.
• W4311585569 cites W3150570549 @default.
• W4311585569 cites W4206731013 @default.
• W4311585569 cites W4207043798 @default.
• W4311585569 cites W4221088803 @default.
• W4311585569 cites W4245793408 @default.
• W4311585569 cites W4280491857 @default.
• W4311585569 doi "https://doi.org/10.1161/hypertensionaha.122.19914" @default.
• W4311585569 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36519433" @default.
• W4311585569 hasPublicationYear "2023" @default.
• W4311585569 type Work @default.
• W4311585569 citedByCount "1" @default.
• W4311585569 countsByYear W43115855692023 @default.
• W4311585569 crossrefType "journal-article" @default.
• W4311585569 hasAuthorship W4311585569A5001111016 @default.
• W4311585569 hasAuthorship W4311585569A5005859926 @default.
• W4311585569 hasAuthorship W4311585569A5006012404 @default.
• W4311585569 hasAuthorship W4311585569A5024409537 @default.
• W4311585569 hasAuthorship W4311585569A5027592431 @default.
• W4311585569 hasAuthorship W4311585569A5028490219 @default.
• W4311585569 hasAuthorship W4311585569A5030723398 @default.
• W4311585569 hasAuthorship W4311585569A5032544653 @default.
• W4311585569 hasAuthorship W4311585569A5037062221 @default.
• W4311585569 hasAuthorship W4311585569A5037407918 @default.
• W4311585569 hasAuthorship W4311585569A5038221232 @default.
• W4311585569 hasAuthorship W4311585569A5040474777 @default.
• W4311585569 hasAuthorship W4311585569A5040644812 @default.
• W4311585569 hasAuthorship W4311585569A5048379858 @default.
• W4311585569 hasAuthorship W4311585569A5051078713 @default.

• next